Journal of Neurosurgery
Posted online on May 26, 2017.
Effect of treatment modality on in-hospital outcome in patients with subarachnoid hemorrhage: a nationwide study in Japan (J-ASPECT Study)
- *Ryota Kurogi, MD1,
- Akiko Kada, MPH2,
- Kunihiro Nishimura, MD, PhD3,
- Satoru Kamitani, MD4,
- AtaruNishimura, MD1,
- Tetsuro Sayama, MD, PhD1,
- Jyoji Nakagawara, MD, PhD5,
- Kazunori Toyoda, MD, PhD6,
- Kuniaki Ogasawara, MD, PhD7,
- Junichi Ono, MD, PhD8,
- Yoshiaki Shiokawa, MD, PhD9,
- Toru Aruga, MD, PhD10,
- Shigeru Miyachi, MD, PhD11,
- Izumi Nagata, MD, PhD12,
- Shinya Matsuda, MD, PhD13,
- ShinichiYoshimura, MD, PhD14,
- Kazuo Okuchi, MD, PhD15,
- Akifumi Suzuki, MD, PhD16,
- Fumiaki Nakamura, MD, PhD4,
- Daisuke Onozuka, PhD17,
- Akihito Hagihara, DMSc, MPH17,
- Koji Iihara, MD, PhD1, and
- the J-ASPECT Study Collaborators
Related Articles
Abstract
OBJECTIVE
Although heterogeneity in patient outcomes following subarachnoid hemorrhage (SAH) has been observed across different centers, the relative merits of clipping and coiling for SAH remain unknown. The authors sought to compare the patient outcomes between these therapeutic modalities using a large nationwide discharge database encompassing hospitals with different comprehensive stroke center (CSC) capabilities.
METHODS
They analyzed data from 5214 patients with SAH (clipping 3624, coiling 1590) who had been urgently hospitalized at 393 institutions in Japan in the period from April 2012 to March 2013. In-hospital mortality, modified Rankin Scale (mRS) score, cerebral infarction, complications, hospital length of stay, and medical costs were compared between the clipping and coiling groups after adjustment for patient-level and hospital-level characteristics by using mixed-model analysis.
RESULTS
Patients who had undergone coiling had significantly higher in-hospital mortality (12.4% vs 8.7%, OR 1.3) and a shorter median hospital stay (32.0 vs 37.0 days, p < 0.001) than those who had undergone clipping. The respective proportions of patients discharged with mRS scores of 3–6 (46.4% and 42.9%) and median medical costs (thousands US$, 35.7 and 36.7) were not significantly different between the groups. These results remained robust after further adjustment for CSC capabilities as a hospital-related covariate.
CONCLUSIONS
Despite the increasing use of coiling, clipping remains the mainstay treatment for SAH. Regardless of CSC capabilities, clipping was associated with reduced in-hospital mortality, similar unfavorable functional outcomes and medical costs, and a longer hospital stay as compared with coiling in 2012 in Japan. Further study is required to determine the influence of unmeasured confounders.
